Click for next page ( 150


The National Academies | 500 Fifth St. N.W. | Washington, D.C. 20001
Copyright © National Academy of Sciences. All rights reserved.
Terms of Use and Privacy Statement



Below are the first 10 and last 10 pages of uncorrected machine-read text (when available) of this chapter, followed by the top 30 algorithmically extracted key phrases from the chapter as a whole.
Intended to provide our own search engines and external engines with highly rich, chapter-representative searchable text on the opening pages of each chapter. Because it is UNCORRECTED material, please consider the following text as a useful but insufficient proxy for the authoritative book pages.

Do not use for reproduction, copying, pasting, or reading; exclusively for search engines.

OCR for page 149
Appendix C Registered Workshop Attendees Olusoji Adeyi Amy Bloom Sector Manager Acting Chief, Infectious Diseases World Bank Division USAID Vincent Ahonkhai Senior Regulatory Affairs Officer Barry Bloom Gates Foundation Harvard University Distinguished Service Professor and Joan L. Sarah Alphs and Julius H. Jacobson Professor Research Associate of Public Health The William Davidson Institute at Harvard School of Public Health the University of Michigan Anthony Boni Rifat Atun Pharmaceutical Specialist Professor of International Health USAID Management Imperial College London Gail Cassell Visiting Professor Jim Barrington Harvard Medical School Global Progam Director Novartis Peter Cegielski Team Leader for Drug-Resistant TB U.S. Centers for Disease Control and Prevention 149

OCR for page 149
150 GLOBAL SUPPLY CHAIN FOR SECOND-LINE DRUGS FOR MDR TB Rajni Chandrasekhar Jose Gomez-Marquez Consultant Director FSG Social Impact Consultants MIT Little Devices Lab Gordon Comstock Andrew Gray Director, Global Supply Chain Senior Lecturer, Pharmaceutical Partnership for Supply Chain Sciences Management School of Health Sciences University of KwaZulu-Natal Henk den Besten Senior Supply Chain Advisor Carol Hamilton Partnership for Supply Chain Senior Scientist Management FHI 360 Lucica Ditiu Debra Hanna Executive Secretary Associate Director, CPTR World Health Organization, Critical Path Institute Stop TB Partnership Lisa Hedman Suzanne Essama-Bibi Project Manager TB Technical Advisor World Health Organization FHI 360 Myriam Henkens David Ferreira International Medical Coordinator Managing Director for Innovative Médecins Sans Frontières Finance GAVI Alliance Brad Herbert Managing Director Gary Filerman Brad Herbert Associates President Atlas Health Foundation Julia Hipps Senior Director Hamish Fraser Eli Lilly and Company Assistant Professor of Medicine Director of Informatics and Maria Insua Telemedicine Senior Technical Advisor Partners In Health University Research Co., LLC Harvard Medical School Douglas Keene Anne Goldfeld Vice President Professor of Medicine Center for Pharmaceutical Global Health Committee Management Harvard Medical School Management Sciences for Health

OCR for page 149
APPENDIX C 151 Joël Keravec Sana Mostaghim Brazil Country Program Director MDR TB Drug Access Project Management Sciences for Health Manager Clinton Health Access Initiative Salmaan Keshavjee Director, Program in Infectious Betsy Myers Disease and Social Change Program Director for Medical Harvard Medical School Research Doris Duke Charitable Foundation Michael Kimerling Senior Program Officer, Norbert Ndjeka Tuberculosis Global Health MDR TB Director Program Department of Health, South Bill & Melinda Gates Foundation Africa Jenna Kohnke Meg O’Brien Program Manager Director, Global Access to Pain American Cancer Society Relief Initiative American Cancer Society Paul Lalvani Director and Dean Christophe Perrin Empower School of Health QA Pharmacist International Union Against Patrick Lukulay Tuberculosis and Lung Disease Vice President Global Health Impact Programs Claire Queresi USP Senior Program Officer Results for Development Institute Robert Matiru (R4D) TB Portfolio Manager UNITAID Iain Richardson World Health Organization Senior Director, Global Supply Chain and Logistics Montserrat Meiro-Lorenzo Eli Lilly and Company Senior Public Health Specialist World Bank David Ripin Executive Vice President of Access Thomas Moore Programs and Chief Scientific World Health Organization, Stop Officer TB Partnership Clinton Health Access Initiative

OCR for page 149
152 GLOBAL SUPPLY CHAIN FOR SECOND-LINE DRUGS FOR MDR TB Owen Robinson Trish Stroman Program Manager Principal Partners In Health The Boston Consulting Group Paul Ryu Jami Taylor Regional Manager of Western Senior Director, Global Access Europe Policy Dong-A Pharmaceutical Co., Ltd. Janssen, The Pharmaceutical Companies of Johnson & Nina Schwalbe Johnson Managing Director, Policy and Performance Cheri Vincent GAVI Alliance TB Team Leader USAID Robert Sebbag Vice President, Access to Medicines Brenda Waning Sanofi Coordinator, Market Dynamics UNITAID Andreas Seiter World Health Organization Senior Health Specialist World Bank Prashant Yadav Director, Healthcare Research Pooja Shaw Initiative Program Officer University of Michigan Results for Development Institute (R4D) Andre Zagorski Principal Technical Advisor for Tracy Sims TB, Center for Pharmaceutical Vice President Management Eli Lilly & Co. Foundation Management Sciences for Health Robert Stanley Manager Partnership for Supply Chain Management